Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Oct 2016 Reuters Investment Profile 12 $20.00

GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review Summary GlaxoSmithKline Plc (GSK) is a healthcare co...

02 Nov 2016 GlobalData 843 $300.00

Trading Report for (GSK). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for GSK. Entry levels, target prices, and risk controls are integral. In addition, free market analy...

02 Nov 2016 Stock Traders Daily 6 $20.00

GSK: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

02 Nov 2016 New Constructs, LLC 10 $25.00

Thomson Reuters Stock Report - GlaxoSmithKline PLC (GSK-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

"The Economy Matters" Report for GLAXF: the economy's impact on GLAXF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

01 Nov 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

GlaxoSmithKline plc ADS

31 Oct 2016 S&P Capital IQ – STARS Reports 11 $127.00

"The Economy Matters" Report for GSK: the economy's impact on GSK's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

30 Oct 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for GSK

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00